nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—TYMS—rectum cancer	0.333	1	CbGaD
Methotrexate—esophageal cancer—rectum cancer	0.179	0.306	CtDrD
Methotrexate—colon cancer—rectum cancer	0.15	0.256	CtDrD
Methotrexate—urinary bladder cancer—rectum cancer	0.134	0.229	CtDrD
Methotrexate—stomach cancer—rectum cancer	0.122	0.208	CtDrD
Methotrexate—GGH—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00286	0.0878	CbGpPWpGaD
Methotrexate—GGH—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00229	0.0703	CbGpPWpGaD
Methotrexate—FOLR1—seminal vesicle—rectum cancer	0.00134	0.0294	CbGeAlD
Methotrexate—Raltitrexed—TYMS—rectum cancer	0.00132	0.32	CrCbGaD
Methotrexate—FPGS—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00128	0.0392	CbGpPWpGaD
Methotrexate—ATIC—One Carbon Metabolism—TYMS—rectum cancer	0.00117	0.0358	CbGpPWpGaD
Methotrexate—FOLR1—epithelium—rectum cancer	0.00117	0.0255	CbGeAlD
Methotrexate—FOLR1—renal system—rectum cancer	0.00108	0.0237	CbGeAlD
Methotrexate—FPGS—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00102	0.0314	CbGpPWpGaD
Methotrexate—Leucovorin—TYMS—rectum cancer	0.000997	0.243	CrCbGaD
Methotrexate—Pralatrexate—TYMS—rectum cancer	0.000997	0.243	CrCbGaD
Methotrexate—SLC46A1—seminal vesicle—rectum cancer	0.000907	0.0199	CbGeAlD
Methotrexate—GGH—seminal vesicle—rectum cancer	0.000892	0.0195	CbGeAlD
Methotrexate—FOLR1—female reproductive system—rectum cancer	0.000867	0.019	CbGeAlD
Methotrexate—ABCC11—female reproductive system—rectum cancer	0.000831	0.0182	CbGeAlD
Methotrexate—Pemetrexed—TYMS—rectum cancer	0.000797	0.194	CrCbGaD
Methotrexate—SLCO4C1—seminal vesicle—rectum cancer	0.000791	0.0173	CbGeAlD
Methotrexate—FPGS—seminal vesicle—rectum cancer	0.000784	0.0172	CbGeAlD
Methotrexate—GGH—Fluoropyrimidine Activity—TP53—rectum cancer	0.00076	0.0233	CbGpPWpGaD
Methotrexate—SLC19A1—female reproductive system—rectum cancer	0.00076	0.0166	CbGeAlD
Methotrexate—GGH—smooth muscle tissue—rectum cancer	0.000747	0.0164	CbGeAlD
Methotrexate—DHFR—G1/S-Specific Transcription—TYMS—rectum cancer	0.000727	0.0223	CbGpPWpGaD
Methotrexate—GGH—renal system—rectum cancer	0.000719	0.0157	CbGeAlD
Methotrexate—GGH—urethra—rectum cancer	0.000706	0.0155	CbGeAlD
Methotrexate—GGH—mammalian vulva—rectum cancer	0.000672	0.0147	CbGeAlD
Methotrexate—ATIC—epithelium—rectum cancer	0.000659	0.0144	CbGeAlD
Methotrexate—SLCO4C1—renal system—rectum cancer	0.000638	0.014	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—rectum cancer	0.000635	0.0139	CbGeAlD
Methotrexate—FPGS—urethra—rectum cancer	0.000621	0.0136	CbGeAlD
Methotrexate—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.000612	0.0188	CbGpPWpGaD
Methotrexate—ATIC—renal system—rectum cancer	0.000611	0.0134	CbGeAlD
Methotrexate—MTHFR—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000601	0.0184	CbGpPWpGaD
Methotrexate—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0006	0.0184	CbGpPWpGaD
Methotrexate—SLCO4C1—mammalian vulva—rectum cancer	0.000596	0.0131	CbGeAlD
Methotrexate—FPGS—mammalian vulva—rectum cancer	0.000591	0.0129	CbGeAlD
Methotrexate—FOLR1—Folate Metabolism—TP53—rectum cancer	0.000576	0.0177	CbGpPWpGaD
Methotrexate—GGH—female reproductive system—rectum cancer	0.000576	0.0126	CbGeAlD
Methotrexate—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.000556	0.017	CbGpPWpGaD
Methotrexate—SLCO3A1—seminal vesicle—rectum cancer	0.000555	0.0121	CbGeAlD
Methotrexate—MTHFR—One Carbon Metabolism—TYMS—rectum cancer	0.000549	0.0168	CbGpPWpGaD
Methotrexate—DHFR—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000534	0.0164	CbGpPWpGaD
Methotrexate—SLCO3A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00053	0.0162	CbGpPWpGaD
Methotrexate—GGH—vagina—rectum cancer	0.000521	0.0114	CbGeAlD
Methotrexate—ATIC—Nucleotide metabolism—TYMS—rectum cancer	0.000514	0.0158	CbGpPWpGaD
Methotrexate—DHFR—seminal vesicle—rectum cancer	0.000509	0.0112	CbGeAlD
Methotrexate—SLCO1C1—renal system—rectum cancer	0.000508	0.0111	CbGeAlD
Methotrexate—FPGS—female reproductive system—rectum cancer	0.000506	0.0111	CbGeAlD
Methotrexate—SLCO4C1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000505	0.0155	CbGpPWpGaD
Methotrexate—SLC22A11—renal system—rectum cancer	0.000494	0.0108	CbGeAlD
Methotrexate—MTHFR—Trans-sulfuration and one carbon metabolism—TYMS—rectum cancer	0.000493	0.0151	CbGpPWpGaD
Methotrexate—PGD—seminal vesicle—rectum cancer	0.00049	0.0107	CbGeAlD
Methotrexate—ATIC—female reproductive system—rectum cancer	0.00049	0.0107	CbGeAlD
Methotrexate—DHFR—One Carbon Metabolism—TYMS—rectum cancer	0.000488	0.015	CbGpPWpGaD
Methotrexate—SLC22A7—renal system—rectum cancer	0.000482	0.0105	CbGeAlD
Methotrexate—MTHFR—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000481	0.0148	CbGpPWpGaD
Methotrexate—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.000467	0.0143	CbGpPWpGaD
Methotrexate—TYMS—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000466	0.0143	CbGpPWpGaD
Methotrexate—SLCO4C1—vagina—rectum cancer	0.000462	0.0101	CbGeAlD
Methotrexate—FPGS—vagina—rectum cancer	0.000458	0.01	CbGeAlD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00045	0.0138	CbGpPWpGaD
Methotrexate—SLCO1B3—vagina—rectum cancer	0.000449	0.00983	CbGeAlD
Methotrexate—SLCO3A1—renal system—rectum cancer	0.000447	0.00979	CbGeAlD
Methotrexate—SLC19A1—lymph node—rectum cancer	0.000445	0.00973	CbGeAlD
Methotrexate—SLCO3A1—urethra—rectum cancer	0.000439	0.00961	CbGeAlD
Methotrexate—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—rectum cancer	0.000438	0.0134	CbGpPWpGaD
Methotrexate—AOX1—seminal vesicle—rectum cancer	0.000432	0.00945	CbGeAlD
Methotrexate—TYMS—smooth muscle tissue—rectum cancer	0.000431	0.00943	CbGeAlD
Methotrexate—ABCC11—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000429	0.0131	CbGpPWpGaD
Methotrexate—DHFR—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000428	0.0131	CbGpPWpGaD
Methotrexate—DHFR—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.000428	0.0131	CbGpPWpGaD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000423	0.013	CbGpPWpGaD
Methotrexate—ABCC10—seminal vesicle—rectum cancer	0.00042	0.00919	CbGeAlD
Methotrexate—SLCO3A1—mammalian vulva—rectum cancer	0.000418	0.00915	CbGeAlD
Methotrexate—DHFR—renal system—rectum cancer	0.000411	0.00899	CbGeAlD
Methotrexate—PGD—smooth muscle tissue—rectum cancer	0.00041	0.00898	CbGeAlD
Methotrexate—DHFR—urethra—rectum cancer	0.000403	0.00883	CbGeAlD
Methotrexate—SLC16A1—epithelium—rectum cancer	0.000397	0.0087	CbGeAlD
Methotrexate—SLC22A11—female reproductive system—rectum cancer	0.000395	0.00866	CbGeAlD
Methotrexate—PGD—renal system—rectum cancer	0.000395	0.00864	CbGeAlD
Methotrexate—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00039	0.012	CbGpPWpGaD
Methotrexate—TYMS—mammalian vulva—rectum cancer	0.000388	0.00849	CbGeAlD
Methotrexate—PGD—urethra—rectum cancer	0.000388	0.00849	CbGeAlD
Methotrexate—ABCC3—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000386	0.0118	CbGpPWpGaD
Methotrexate—DHFR—mammalian vulva—rectum cancer	0.000384	0.0084	CbGeAlD
Methotrexate—PGD—mammalian vulva—rectum cancer	0.000369	0.00808	CbGeAlD
Methotrexate—SLC16A1—renal system—rectum cancer	0.000368	0.00807	CbGeAlD
Methotrexate—MTHFR—female reproductive system—rectum cancer	0.000364	0.00797	CbGeAlD
Methotrexate—ABCC4—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000363	0.0111	CbGpPWpGaD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00036	0.0111	CbGpPWpGaD
Methotrexate—SLCO1B1—renal system—rectum cancer	0.000358	0.00785	CbGeAlD
Methotrexate—SLCO3A1—female reproductive system—rectum cancer	0.000358	0.00784	CbGeAlD
Methotrexate—AOX1—renal system—rectum cancer	0.000348	0.00761	CbGeAlD
Methotrexate—SLC46A1—lymph node—rectum cancer	0.000342	0.0075	CbGeAlD
Methotrexate—AOX1—urethra—rectum cancer	0.000342	0.00748	CbGeAlD
Methotrexate—ABCC3—renal system—rectum cancer	0.00034	0.00744	CbGeAlD
Methotrexate—FPGS—Fluoropyrimidine Activity—TP53—rectum cancer	0.00034	0.0104	CbGpPWpGaD
Methotrexate—ABCC10—renal system—rectum cancer	0.000338	0.00741	CbGeAlD
Methotrexate—GGH—lymph node—rectum cancer	0.000337	0.00737	CbGeAlD
Methotrexate—ABCC10—urethra—rectum cancer	0.000332	0.00728	CbGeAlD
Methotrexate—TYMS—female reproductive system—rectum cancer	0.000332	0.00727	CbGeAlD
Methotrexate—DHFR—female reproductive system—rectum cancer	0.000329	0.0072	CbGeAlD
Methotrexate—AOX1—mammalian vulva—rectum cancer	0.000325	0.00712	CbGeAlD
Methotrexate—SLCO3A1—vagina—rectum cancer	0.000324	0.00709	CbGeAlD
Methotrexate—ABCC10—mammalian vulva—rectum cancer	0.000317	0.00693	CbGeAlD
Methotrexate—PGD—female reproductive system—rectum cancer	0.000316	0.00692	CbGeAlD
Methotrexate—ABCC3—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000309	0.00947	CbGpPWpGaD
Methotrexate—TYMS—vagina—rectum cancer	0.0003	0.00657	CbGeAlD
Methotrexate—DHFR—vagina—rectum cancer	0.000297	0.00651	CbGeAlD
Methotrexate—ABCC1—seminal vesicle—rectum cancer	0.000297	0.0065	CbGeAlD
Methotrexate—FPGS—lymph node—rectum cancer	0.000296	0.00648	CbGeAlD
Methotrexate—SLC16A1—female reproductive system—rectum cancer	0.000295	0.00646	CbGeAlD
Methotrexate—SLCO1A2—renal system—rectum cancer	0.000292	0.00639	CbGeAlD
Methotrexate—ABCC4—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00029	0.00891	CbGpPWpGaD
Methotrexate—SLCO1B1—female reproductive system—rectum cancer	0.000287	0.00628	CbGeAlD
Methotrexate—ATIC—lymph node—rectum cancer	0.000286	0.00627	CbGeAlD
Methotrexate—PGD—vagina—rectum cancer	0.000286	0.00626	CbGeAlD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000284	0.00871	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000284	0.00871	CbGpPWpGaD
Methotrexate—ABCC4—renal system—rectum cancer	0.000281	0.00615	CbGeAlD
Methotrexate—SLC22A8—renal system—rectum cancer	0.000279	0.0061	CbGeAlD
Methotrexate—AOX1—female reproductive system—rectum cancer	0.000278	0.0061	CbGeAlD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000278	0.00853	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000273	0.00837	CbGpPWpGaD
Methotrexate—ABCC3—female reproductive system—rectum cancer	0.000272	0.00596	CbGeAlD
Methotrexate—ABCC2—renal system—rectum cancer	0.000272	0.00595	CbGeAlD
Methotrexate—ABCC10—female reproductive system—rectum cancer	0.000271	0.00593	CbGeAlD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000269	0.00825	CbGpPWpGaD
Methotrexate—ABCG2—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.000266	0.00816	CbGpPWpGaD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000257	0.00787	CbGpPWpGaD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000252	0.00774	CbGpPWpGaD
Methotrexate—AOX1—vagina—rectum cancer	0.000252	0.00551	CbGeAlD
Methotrexate—ABCG2—seminal vesicle—rectum cancer	0.000246	0.00538	CbGeAlD
Methotrexate—ABCC10—vagina—rectum cancer	0.000245	0.00537	CbGeAlD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00024	0.00735	CbGpPWpGaD
Methotrexate—SLCO1C1—lymph node—rectum cancer	0.000238	0.00521	CbGeAlD
Methotrexate—ABCC1—urethra—rectum cancer	0.000235	0.00515	CbGeAlD
Methotrexate—SLC19A1—Folate Metabolism—TP53—rectum cancer	0.000229	0.00703	CbGpPWpGaD
Methotrexate—DHFR—E2F transcription factor network—TYMS—rectum cancer	0.000227	0.00695	CbGpPWpGaD
Methotrexate—ABCC4—female reproductive system—rectum cancer	0.000225	0.00492	CbGeAlD
Methotrexate—ABCC1—mammalian vulva—rectum cancer	0.000224	0.0049	CbGeAlD
Methotrexate—ABCC2—female reproductive system—rectum cancer	0.000218	0.00476	CbGeAlD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000215	0.0066	CbGpPWpGaD
Methotrexate—ABCG2—Fluoropyrimidine Activity—TYMS—rectum cancer	0.000213	0.00653	CbGpPWpGaD
Methotrexate—MTHFR—lymph node—rectum cancer	0.000213	0.00466	CbGeAlD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000212	0.00651	CbGpPWpGaD
Methotrexate—SLCO3A1—lymph node—rectum cancer	0.000209	0.00459	CbGeAlD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.000197	0.00604	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000196	0.006	CbGpPWpGaD
Methotrexate—ABCG2—urethra—rectum cancer	0.000195	0.00426	CbGeAlD
Methotrexate—TYMS—lymph node—rectum cancer	0.000194	0.00425	CbGeAlD
Methotrexate—DHFR—lymph node—rectum cancer	0.000192	0.00421	CbGeAlD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000188	0.00578	CbGpPWpGaD
Methotrexate—ABCG2—mammalian vulva—rectum cancer	0.000185	0.00406	CbGeAlD
Methotrexate—PGD—lymph node—rectum cancer	0.000185	0.00405	CbGeAlD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000177	0.00543	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—RAB1A—rectum cancer	0.000175	0.00537	CbGpPWpGaD
Methotrexate—ABCC1—vagina—rectum cancer	0.000173	0.0038	CbGeAlD
Methotrexate—SLC16A1—lymph node—rectum cancer	0.000173	0.00378	CbGeAlD
Methotrexate—TYMS—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.000171	0.00524	CbGpPWpGaD
Methotrexate—DHFR—G1/S Transition—TYMS—rectum cancer	0.000164	0.00504	CbGpPWpGaD
Methotrexate—AOX1—lymph node—rectum cancer	0.000163	0.00357	CbGeAlD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.000161	0.00494	CbGpPWpGaD
Methotrexate—MTHFR—Fluoropyrimidine Activity—TP53—rectum cancer	0.00016	0.0049	CbGpPWpGaD
Methotrexate—ABCC3—lymph node—rectum cancer	0.000159	0.00349	CbGeAlD
Methotrexate—ABCC10—lymph node—rectum cancer	0.000159	0.00347	CbGeAlD
Methotrexate—TYMS—Cell Cycle—RAB1A—rectum cancer	0.000153	0.00469	CbGpPWpGaD
Methotrexate—SLC46A1—Folate Metabolism—TP53—rectum cancer	0.000152	0.00466	CbGpPWpGaD
Methotrexate—ABCG2—vagina—rectum cancer	0.000144	0.00314	CbGeAlD
Methotrexate—DHFR—Fluoropyrimidine Activity—TP53—rectum cancer	0.000142	0.00435	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000141	0.00434	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000139	0.00425	CbGpPWpGaD
Methotrexate—DHFR—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.000139	0.00425	CbGpPWpGaD
Methotrexate—ALB—lymph node—rectum cancer	0.000136	0.00297	CbGeAlD
Methotrexate—ABCC4—lymph node—rectum cancer	0.000132	0.00288	CbGeAlD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000128	0.00393	CbGpPWpGaD
Methotrexate—ABCC2—lymph node—rectum cancer	0.000127	0.00279	CbGeAlD
Methotrexate—TYMS—Fluoropyrimidine Activity—TP53—rectum cancer	0.000124	0.0038	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000122	0.00374	CbGpPWpGaD
Methotrexate—ABCB1—seminal vesicle—rectum cancer	0.000121	0.00265	CbGeAlD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—TP53—rectum cancer	0.00012	0.00367	CbGpPWpGaD
Methotrexate—ABCC1—lymph node—rectum cancer	0.000112	0.00245	CbGeAlD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00011	0.00337	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000108	0.00331	CbGpPWpGaD
Methotrexate—ABCB1—epithelium—rectum cancer	0.000105	0.00231	CbGeAlD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000103	0.00317	CbGpPWpGaD
Methotrexate—ABCC3—Fluoropyrimidine Activity—TP53—rectum cancer	0.000102	0.00314	CbGpPWpGaD
Methotrexate—ABCB1—renal system—rectum cancer	9.77e-05	0.00214	CbGeAlD
Methotrexate—ABCC4—Fluoropyrimidine Activity—TP53—rectum cancer	9.63e-05	0.00295	CbGpPWpGaD
Methotrexate—ABCB1—urethra—rectum cancer	9.6e-05	0.0021	CbGeAlD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	9.57e-05	0.00294	CbGpPWpGaD
Methotrexate—ABCG2—lymph node—rectum cancer	9.28e-05	0.00203	CbGeAlD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	9.21e-05	0.00282	CbGpPWpGaD
Methotrexate—MTHFR—Folate Metabolism—TP53—rectum cancer	9.17e-05	0.00281	CbGpPWpGaD
Methotrexate—ABCB1—mammalian vulva—rectum cancer	9.14e-05	0.002	CbGeAlD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC14A2—rectum cancer	9e-05	0.00276	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.72e-05	0.00267	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.62e-05	0.00264	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	8.19e-05	0.00251	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TP53—rectum cancer	8.15e-05	0.0025	CbGpPWpGaD
Methotrexate—ABCB1—female reproductive system—rectum cancer	7.83e-05	0.00171	CbGeAlD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	7.58e-05	0.00233	CbGpPWpGaD
Methotrexate—ABCB1—vagina—rectum cancer	7.08e-05	0.00155	CbGeAlD
Methotrexate—ABCG2—Fluoropyrimidine Activity—TP53—rectum cancer	7.06e-05	0.00217	CbGpPWpGaD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—NRAS—rectum cancer	7.01e-05	0.00215	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ITGA2—rectum cancer	6.77e-05	0.00207	CbGpPWpGaD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	6.53e-05	0.002	CbGpPWpGaD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—KRAS—rectum cancer	6.04e-05	0.00185	CbGpPWpGaD
Methotrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	5.7e-05	0.00175	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—TYMS—rectum cancer	5.5e-05	0.00169	CbGpPWpGaD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—HRAS—rectum cancer	5.13e-05	0.00157	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—TYMS—rectum cancer	5.08e-05	0.00156	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ITGA2—rectum cancer	5.04e-05	0.00155	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC14A2—rectum cancer	4.68e-05	0.00143	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—TYMS—rectum cancer	4.67e-05	0.00143	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—TYMS—rectum cancer	4.67e-05	0.00143	CbGpPWpGaD
Methotrexate—ABCB1—lymph node—rectum cancer	4.58e-05	0.001	CbGeAlD
Methotrexate—DHFR—Cell Cycle—TYMS—rectum cancer	4.54e-05	0.00139	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	4.1e-05	0.00126	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—TYMS—rectum cancer	3.64e-05	0.00112	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	3.42e-05	0.00105	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TYMS—rectum cancer	3.33e-05	0.00102	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	3.04e-05	0.000932	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—rectum cancer	2.92e-05	0.000894	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—NRAS—rectum cancer	2.85e-05	0.000873	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	2.83e-05	0.000867	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—rectum cancer	2.5e-05	0.000768	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—KRAS—rectum cancer	2.45e-05	0.000751	CbGpPWpGaD
Methotrexate—FPGS—Disease—NRAS—rectum cancer	2.42e-05	0.000742	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ITGA2—rectum cancer	2.28e-05	0.0007	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TYMS—rectum cancer	2.2e-05	0.000674	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TYMS—rectum cancer	2.15e-05	0.000658	CbGpPWpGaD
Methotrexate—FPGS—Disease—KRAS—rectum cancer	2.08e-05	0.000639	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HRAS—rectum cancer	2.08e-05	0.000638	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TYMS—rectum cancer	1.95e-05	0.000599	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NRAS—rectum cancer	1.9e-05	0.000583	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NRAS—rectum cancer	1.88e-05	0.000578	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TYMS—rectum cancer	1.78e-05	0.000545	CbGpPWpGaD
Methotrexate—FPGS—Disease—HRAS—rectum cancer	1.77e-05	0.000543	CbGpPWpGaD
Methotrexate—PGD—Disease—NRAS—rectum cancer	1.72e-05	0.000529	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—KRAS—rectum cancer	1.64e-05	0.000502	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KRAS—rectum cancer	1.62e-05	0.000498	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TYMS—rectum cancer	1.56e-05	0.000479	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—rectum cancer	1.51e-05	0.000462	CbGpPWpGaD
Methotrexate—PGD—Disease—KRAS—rectum cancer	1.48e-05	0.000455	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—rectum cancer	1.45e-05	0.000446	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NRAS—rectum cancer	1.42e-05	0.000435	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TYMS—rectum cancer	1.41e-05	0.000432	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HRAS—rectum cancer	1.39e-05	0.000427	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HRAS—rectum cancer	1.38e-05	0.000423	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—rectum cancer	1.31e-05	0.000403	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—rectum cancer	1.26e-05	0.000387	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TYMS—rectum cancer	1.23e-05	0.000377	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KRAS—rectum cancer	1.22e-05	0.000374	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NRAS—rectum cancer	1.14e-05	0.000349	CbGpPWpGaD
Methotrexate—AOX1—Disease—NRAS—rectum cancer	1.11e-05	0.000341	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TYMS—rectum cancer	1.1e-05	0.000339	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—rectum cancer	1.08e-05	0.000333	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	1.05e-05	0.000323	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TYMS—rectum cancer	1.05e-05	0.000322	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—rectum cancer	1.04e-05	0.000318	CbGpPWpGaD
Methotrexate—DHFR—Disease—NRAS—rectum cancer	1.01e-05	0.00031	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KRAS—rectum cancer	9.79e-06	0.0003	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TYMS—rectum cancer	9.72e-06	0.000298	CbGpPWpGaD
Methotrexate—AOX1—Disease—KRAS—rectum cancer	9.56e-06	0.000293	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	9.37e-06	0.000287	CbGpPWpGaD
Methotrexate—DHFR—Disease—KRAS—rectum cancer	8.7e-06	0.000267	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—rectum cancer	8.32e-06	0.000255	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—rectum cancer	8.13e-06	0.000249	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—rectum cancer	7.39e-06	0.000227	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NRAS—rectum cancer	6.41e-06	0.000197	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TYMS—rectum cancer	6e-06	0.000184	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NRAS—rectum cancer	5.72e-06	0.000175	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KRAS—rectum cancer	5.52e-06	0.000169	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TYMS—rectum cancer	5.26e-06	0.000161	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KRAS—rectum cancer	4.92e-06	0.000151	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—rectum cancer	4.91e-06	0.00015	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—rectum cancer	4.69e-06	0.000144	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—rectum cancer	4.18e-06	0.000128	CbGpPWpGaD
